Intrathecal thyroid autoantibody synthesis in a subgroup of patients with schizophreniform syndromes

Dominique Endres*, Rick Dersch, Benedikt Hochstuhl, Bernd Fiebich, Tilman Hottenrott, Evgeniy Perlov, Simon Maier, Benjamin Berger, Annette Baumgartner, Nils Venhoff, Oliver Stich, Ludger Tebartz van Elst

*Corresponding author for this work
16 Citations (Scopus)

Abstract

Schizophreniform syndromes in combination with autoimmune thyroiditis and increased serum thyroid antibodies lead healthcare practitioners to consider a diagnosis of Hashimoto’s encephalopathy. To detect specific biomarkers, the authors analyzed whether intrathecal antithyroid antibody synthesis occurred in a subgroup of schizophreniform patients. In doing so, the authors analyzed thyroid antibodies in paired cerebrospinal fluid and serum samples from 100 schizophreniform patients. Increased antibody indices (AIs) for antithyroid peroxidase or antithyroglobulin autoantibodies in 13 schizophreniform patients were found. AIs were increased in 68% of the seropositive patients. These findings support the hypothesis that autoimmune processes may contribute to the pathophysiology in these patients.

Original languageEnglish
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Volume29
Issue number4
Pages (from-to)365-374
Number of pages10
ISSN0895-0172
DOIs
Publication statusPublished - 01.09.2017

Funding

Supported by the Department for Psychiatry and Psychotherapy of the University Medical Center Freiburg. BF has received grant and research support from Bayer Vital GmbH. TH has received travel grants from Bayer Vital GmbH and Novartis. BB has received travel grants from Bayer Vital GmbH, Ipsen Pharma GmbH, and Genzyme. AB has received consulting and lecture fees, as well as grant and research support, from Bayer Vital GmbH, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis, and Teva. NV has served on advisory boards of, has participated in lectures for, and/or received research or travel grants from AbbVie, GSK, Janssen-Cilag, Medac, Novartis, and Roche. OS has received consulting and lecture fees and grant and research support from Bayer Vital GmbH, Biogen Idec, Genzyme, Merck Serono, Novartis, Sanofi-Aventis, and Teva. LTvE has served on advisory boards of, has participated in lectures for, and/or received travel grants from Cyberonics, Eli Lilly, GlaxoSmithKline, Janssen, Janssen-Cilag, Novartis, Servier, Shire, and UCB. All other authors report no financial relationships with commercial interests.

Research Areas and Centers

  • Health Sciences

DFG Research Classification Scheme

  • 2.22-22 Clinical Immunology and Allergology
  • 2.23-09 Biological Psychiatry

Fingerprint

Dive into the research topics of 'Intrathecal thyroid autoantibody synthesis in a subgroup of patients with schizophreniform syndromes'. Together they form a unique fingerprint.

Cite this